Clinical Trial Update: Study Evaluating Desvenlafaxine Succinate Sustained-Release Tablets (DVS SR) In The Treatment Of Child and Adolescent Outpatients With Major Depressive Disorder [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating desvenlafaxine succinate sustained-release tablets (DVS SR) for Major Depressive Disorder in children and adolescents; trial c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Desvenlafaxine succinate sustained-release tablets (desvenlafaxine succinate)

Snippet

Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer | Conditions: Depressive Disorder, Major Depressive Disorder | Phase 2 | Status: COMPLETED | Results posted: 2011-05-16